1246 — Boill Healthcare Holdings Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual cashflow statement for Boill Healthcare Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -203 | -181 | -745 | -225 | — |
Depreciation | |||||
Non-Cash Items | 155 | 114 | 774 | 198 | — |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 111 | -106 | -165 | 94 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 72.8 | -153 | -114 | 68.2 | — |
Capital Expenditures | -5.14 | -0.182 | -3.7 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -12 | 53 | -572 | 409 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.1 | 52.9 | -576 | 409 | — |
Financing Cash Flow Items | -79.4 | 294 | -118 | -636 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -17.3 | 132 | 602 | -482 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 32.8 | 36.4 | -84.8 | -5.88 | — |